Veracyte Inc, based in Richmond, VA, is a leading provider of molecular diagnostic tests for a range of diseases, with a focus on cancer. Their innovative tests, such as the Afirma Genomic Sequencing Classifier for thyroid cancer and the Prosigna Breast Cancer Assay, empower clinicians and patients with high-value insights to make more informed treatment decisions.
With a proven framework that identifies clinical unmet needs, develops high-performance tests, and ramps up patient testing globally, Veracyte is dedicated to elevating the standard of care for cancer patients worldwide. Their commitment to making leading diagnostics accessible globally underscores their mission to transform cancer care and improve patient outcomes.
Generated from the website